Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

1.370 -0.030 (-2.14%)
Streaming Delayed Price Updated: 11:50 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Redhill Biopharma Ltd. - American Depositary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib
Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The... 
From RedHill Biopharma Ltd
Via AccessWire
News headline image
64 Biggest Movers From Yesterday ↗
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... 
Via Benzinga
News headline image
RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea ↗
 
Via Benzinga
News headline image
Redhill Biopharma: Q4 Earnings Insights ↗
Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
Earnings Scheduled For March 17, 2022 ↗
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
Via Benzinga
News headline image
Redhill Biopharma's Earnings: A Preview ↗
Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced topline results from the Phase 2 part of the Phase 2/3 study of RHB-107 (upamostat) in non-hospitalized... 
Via Benzinga
News headline image
RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced results from two recently completed prespecified analyses from the oral opaganib Phase 2/3 study in hospitalized severe COVID-19.  
Via Benzinga
News headline image
18 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc... 
Via Benzinga
News headline image
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients. The... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
Via Benzinga
News headline image
63 Biggest Movers From Yesterday ↗
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX 
Via Benzinga
News headline image
44 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future... 
Via Benzinga
News headline image
RedHill Announces Additional Insider Buying
RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that... 
From RedHill Biopharma Ltd
Via AccessWire
News headline image
Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗
Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
News headline image
RedHill Biopharma's Talicia Recommended For H. Pylori Infection ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed prescribing of... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication Despite increasing... 
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) announced that opaganib's proposed mechanism of action is not impacted by spike protein mutations. Opaganib is expected to be... 
Via Benzinga
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not... 
Via FinancialNewsMedia
News headline image
RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations
Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale... 
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI ↗
RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection. The new publication, describing a ... 
Via Benzinga
News headline image
RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI
RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI High Body Mass Index and obesity are known risk factors for H. Pylori eradication... 
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
RedHill’s Movantik Added To Medicare Formulary
RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans Movantik® approved for inclusion as preferred and unrestricted... 
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... 
Via Benzinga
News headline image
RedHill Reports 3Q/2021 Financial Results
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against... 
From RedHill Biopharma Ltd
Via AccessWire
Topics Intellectual Property Regulatory Compliance
News headline image
Earnings Scheduled For November 30, 2021 ↗
Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is estimated to report quarterly earnings at $0.31 per share on revenue of $573.63 million. • UP... 
Via Benzinga
News headline image
Earnings Preview For Redhill Biopharma ↗
Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Tuesday, 2021-11-30. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
52 Biggest Movers From Friday ↗
Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.